INTRODUCTION
caused by thalidomide in 1961, with the 16 th World Health reiterated the need for early intervention with regard to the rapid dissemination of information on adverse drug reactions Health Organization (WHO) of a pilot research project for international drug monitoring. [1] The purpose of this was to develop a system, applicable internationally, for detecting previously unknown or poorly understood adverse effects of medicines. From this, practice and science of PV emerged. detection, assessment, understanding and prevention of adverse effects and of all other drug problems. [1] Furthermore, the WHO program for international drug monitoring aims at developing a comprehensive global PV strategy that responds to the health-care needs of all countries. [4] As previously stated by the program for international drug control. Under this program, systems have been created in Member States for the collection and evaluation of individual case safety reports (ICSRs). [5] ADRs knowledge led to increased recognition and reporting caused by ADRs and these are the fourth and the sixth most common cause of death. [6] Furthermore, the increase in the average age of the population is related to a proportional increase in the number of drugs used (due to the prevalence of chronic diseases, such as hypertension, heart failure, glaucoma, prostatic hyperplasia, diabetes, etc.) resulting in an exponential increase of the ADRs. Other possible causes are the rapid development of new molecules for diseases previously intractable and new treatment alternatives for other of drugs commercially available. This can generate a lack of health professionals knowledge about the potential adverse effects due to drug-drug interactions or contraindications of some dugs caused by improper use.
Furthermore, the introduction of generic drugs has also increased the number of patients not responding to treatments or with ADRs due to increased bioavailability.
In all countries, PV systems rely on spontaneous (or voluntary) communication, in which suspected ADRs are reported by the medical staff or by patients themselves to a national health coordinating center. The spontaneous reporting systems provide the highest volume of information at the lowest maintenance cost and have established their value in the early diagnosis of problems related to safety in patients or their products or their use. [14] Most important function of the signals [15] and the formulation of hypotheses, which leads to risks related to the use of a medication, any possible changes in the package insert and give updated information product. [16] In some cases, the withdrawal of marketing authorizations are also based on ICSRs, for example, in the case of cerivastatin, an association (a "signal") among cerivastatin, myopathy and rhabdomyolysis has been published on the basis of ICSRs, from the Uppsala Monitoring Centre in 1999 and various in different countries. Unfortunately not in all countries, the voluntary reporting reaches standard levels set by the WHO under-reporting, according to literature data, appear to be due to: Lack of knowledge (it is believed that only serious adverse reactions should be reported), lack of interest or time, the indifference to the problem, the uncertainty about the causal link between a drug and an ADR; the mistaken belief that only safe drugs are marketed. [19] For these reasons, Agenzia Italiana del Farmaco (AIFA) has been promoting several projects on the whole national territory and managed at regional level, in order to increase "PV Culture".
One of these structures "Regional network of drug information: "Mater Domini" University Hospital of Catanzaro, in order inform the community on PV issue, indirectly increasing the number of spontaneously reported ADRs in the region.
The components of this project are carrying out various activities in the whole Calabria regional territory by involving the various training health workers, doctors, pharmacists and structures health facilities. This collaboration has increased the quality and quantity of reports of suspected ADRs and vaccines; AIFA projects by increasing awareness about PV surely help in improving the status of ADRs reporting.
In Italy, the actual situation of spontaneous reports of ADRs is
In the present study, we report an analysis of the ADRs possible corrections to improve the system in Calabria or to be used in other countries.
MATERIALS AND METHODS
All reports of ADR relating to Calabria region were obtained from the database through portal National Health Information System (NSIS) AIFA, a system specifically designed to handle the reporting of ADRs. These reports collected in the analysis including ADRs severity, the pharmacological class causing ADRs and the kind of reporter. A total of 461 ADRs were present in the database in the period 1 st st
RESULTS

ADRs analysis
The ADRs' reports present in the national network of PV via analysis showed a higher incidence of ADRs in the age group between 41 and 65 years old, followed by the series "over 65" this age group. In fact, in the "age 41-65" group, 61 patients of In details, in reaction was severe [ Figure 1 ]. Furthermore, in the age group By comparing all age groups the minor onset of ADRs was in the In the age group 41-65, drugs that have given more ADRs were pharmacological class of antimicrobial it is possible to observe a homogenous number of ADRs in all the range age; the antiepileptic drugs have caused the major number of ADRs showed gender differences for the reporting; ADRs in men a higher number of ADRs for women has been reported serious adverse events was reported for antibacterial agents Further analysis showed that the class of drugs, which caused 
DISCUSSION
positive trend of spontaneous reporting in the Calabria region reached; however, the mechanism set up has already collected th of May. Up to date, the number is already very close to the previous year and very This result was achieved by an intensive activity of information to health professionals by the organization of 5 regional advertisement on the role of the PV center and the importance of PV has been pursued at all levels including brief meetings in hospitals or publications on newspapers. Finally, a strong collaboration based on selected local project has led to the creation of small professional networks paying particular attention to the development of ADRs and drug safety. All together, the continuous feedback obtained by health professionals increased the general knowledge on PV. a high participation of specialist doctors mainly working in hospitals and general practitioners; very relevant is the increase observed for pharmacists in comparison to the previous year nurses remains very low despite the fact that them together with ADRs; furthermore, no spontaneous reports from patients were uploaded into the system. The reasons for such a result might be various (see below); however, in some cases nurses observed the ADR and then the physician reported it, whereas despite the increment in the number of reports by pharmacists, this class could undoubtedly increase their participation to the system. These data, although many measures have been put in place to increase the PV culture at regional, national and global levels, it must be admitted that still more job has to be done in order to move out of this under-reporting condition.
Under-reporting has many causes: The detectors often look for a certain temporality and causality between ADRs and drug before reporting the event; sometimes the reports are of poor quality or incomplete and cannot be inserted into the system; there is an underutilization of the latest technological communication means; very often the reporters complain about inhabitants ADRs were reported keeping Italy beyond the standard set by WHO. Although the gold standard (GD) has been achieved at national level, the number of reports is not homogenous in the country and there are regions that exceed the GD and other, which are far below.
Among the various Italian regions, a strong discrepancy can be evidences; in fact, there are regions such as Lombardia, which holds the largest number of signals there are regions still far from reaching the GD such as Lazio where new active centers of PV started their work or were maintained. These data demonstrate the importance of the role can be implemented as a result of an appropriate intervention policy. The number of professionals that send signals is still that the world medical-health is sensitive to the problem; surely all the interventions put in place in recent years have increased PV culture.
CONCLUSION
In conclusion, Italy at national level has reached and exceeded the GD pre-set by the WHO and has shown an important growth increase in the total number of ADRs. The region Calabria has reached yet the GD it has shown one of the largest increase.
The positive trend is encouraging and the work of the regional center is reaching satisfactory levels. The activities organized (CME) courses, have led to good results (the current ADRs count for this year is very encouraging). More generally, the role of PV regional centers seems to be necessary to the correct functioning of this machine. In the past, when such centers activities were stopped, due to lack of funding, the number of ADRs dropped down to unsatisfactory levels. Therefore, information and support must continue in the next coming years at least until PV culture gets a widespread diffusion starting to be self-sustained. In any case, the relevance of PV to patients' safety and pharmacoeconomy should be a primary aim in all countries.
